naion glp-1 GLP-1s are changing bodiesβ¦ but what about the eyes? π Here's what the current research shows: β« Rapid A1C reduction can trigger early worsening of DR (especially in moderate+ NPDR) β« More GLP-1 medications and eye problem
Description
Trends in FDA FY2024 Inspection-Based Warning Letters, supra note 3
At Conceive NJ, those discussions are handled through shared decision-making with the patient and the broader care team

Liraglutide in clinical trials The clinical efficacy of once-daily liraglutide in patients with T2D was demonstrated in a study series entitled LEAD (Liraglutide Effect and Action in Diabetes)

it should be avoided

The patient portal carried no tracking information at all

GLP-1 medications aren't appropriate for everyone, and the evaluation determines whether they're right for you
